[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery]. - Suppr | 超能文献

[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].

作者信息

van der Meer F J, Rosendaal F R

出版信息

Ned Tijdschr Geneeskd. 1993 Oct 23;137(43):2223-4; author reply 2224-5.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].

Ned Tijdschr Geneeskd. 1993 Oct 23;137(43):2223-4; author reply 2224-5.

2

[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].

Ned Tijdschr Geneeskd. 1993 Oct 23;137(43):2222-3.

3

[No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].

Ned Tijdschr Geneeskd. 1994 Feb 19;138(8):426-7.

4

[No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].

Ned Tijdschr Geneeskd. 1994 Jan 1;138(1):46-7.

5

[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].

Ned Tijdschr Geneeskd. 1993 Oct 23;137(43):2223.

6

[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].

Ned Tijdschr Geneeskd. 1993 Oct 23;137(43):2225; author reply 2225-6.

7

[No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].

Ned Tijdschr Geneeskd. 1993 Dec 18;137(51):2669.

8

[Prevention of occlusion following peripheral bypass surgery using oral anticoagulants or acetylsalicylic acid: a randomized comparison within the Dutch BOA study].

Ned Tijdschr Geneeskd. 1995 Jul 22;139(29):1504-6.

9

[Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].

Schweiz Med Wochenschr. 1988 Mar 26;118(12):447-9.

10

[Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].

Helv Chir Acta. 1987 Feb;53(4):497-500.

引用本文的文献

1

Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.

Crit Care. 2012 Oct 4;16(5):R185. doi: 10.1186/cc11669.